Guilt over a young man's sudden death - Sarasota Herald-Tribune

Sarasota Herald-Tribune

Guilt over a young man's sudden death Sarasota Herald-Tribune DONOHUE: As I was suffering gout for more than 10 years, and as you know about my country, please let me get your suggestion and advisement for treatment. I will be very happy if you can do this. Thanks for your help. I am eagerly waiting for your ... Dear Dr. Donohue: No one guilty of neglect in young man's deathHerald & Review all 7 news articles »

FDA Panel Unanimously Rejects Regeneron's Arcalyst As Gout Treatment - Wall Street Journal

French Tribune

FDA Panel Unanimously Rejects Regeneron's Arcalyst As Gout Treatment Wall Street Journal By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--A federal advisory panel unanimously rejected Regeneron Pharmaceuticals Inc.'s (REGN) Arcalyst has a proposed treatment for gout, saying current safety data was inadequate to ... Regeneron's Arcalyst Fails to Win Panel Backing for GoutBloomberg Regeneron Dips on Safety Concern Over Gout Treatment [UPDATE]Minyanville.com FDA Review Has Safety Issues with Gout DrugMedPage Today pharmabiz.com -CBS News -WTAQ all 51 news articles »

Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... - MarketWatch (press release)

Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... MarketWatch (press release) Although PFS was numerically higher in patients treated with temsirolimus, the difference was not statistically significant. Overall survival, a secondary endpoint in the study, showed statistical significance favoring patients randomized to the ... and more »

FDA: Regeneron Drug Offers 'Small' Benefit In Gout - Wall Street Journal

FDA: Regeneron Drug Offers 'Small' Benefit In Gout Wall Street Journal By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--The US Food and Drug Administration said that the treatment effect from a proposed Regeneron Pharmaceuticals Inc. (REGN) treatment for gout was "small," and the agency raised ... Arcalyst: Gout Drug Is Effective, But Side Effects Questioned By FDAHuffington Post FDA notes cancer cases linked to Regeneron gout drugFierceBiotech Regeneron Dips on Safety Concern Over Gout TreatmentMinyanville.com BusinessWeek all 26 news articles »